American Society of Hirudotherapy

Bundesamt für Sicherheit im Gesundheitswesen

BASG · Austria · europe

Regulatory jurisdiction profileJurisdictional reference
Medical device clearednational regulator

Austria's federal authority for safety in health care — applies EU MDR directly; leech-specific regulation has not been independently verified by ASH and is presumed to follow the general EU medical-device framework.

Regulatory Profile

Agency type
national regulator
Region
europe
Country
Austria
Leech status
medical device cleared
Last ASH review
2026-05-25

Relevant Regulation Codes

  • Medizinproduktegesetz 2021 (MPG 2021) — Austrian implementation of MDR
  • Regulation (EU) 2017/745 (MDR) — direct effect

Prescriber Requirements

  • Physician (Arzt) prescription required under Austrian medical practice law
  • Specific scope of non-physician practitioners (e.g., Heilmasseur) for leech therapy has not been independently verified by ASH

Supply Chain & GMP

EU MDR-aligned manufacturer / authorised representative registration via BASG / AGES Medizinmarktaufsicht; German-language labelling per Austrian consumer-protection law.

Import/Export Rules

Intra-EU free movement for CE-marked devices. Third-country imports require BASG notification plus standard CITES Appendix II paperwork for Hirudo medicinalis and live-invertebrate veterinary clearance.

Reimbursement Context

ÖGK (Österreichische Gesundheitskasse) coverage for inpatient indications via DRG bundling; specific outpatient hirudotherapy reimbursement status not independently verified by ASH.

ASH Editorial Notes

Austria's leech-specific regulation has not been independently verified by ASH; the entry reflects the default EU MDR framework expected to apply. Austrian clinical use of hirudotherapy has historic anchor points in Vienna's traditional medicine community but precise regulatory references should be confirmed before relying on this entry for compliance decisions.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.